Search research articles
Contact Us
Filters
Showing results (71-80 of 115) with videos related to
Page
of 12
Sort By:
Journal of Gastrointestinal Oncology
|
March 12, 2026
The association between adherence to elective nodal volume guidelines and reduced distant metastasis in esophageal and gastroesophageal junction cancer: a retrospective analysis of elective nodal irradiation
Jared Lyons, Garrett Harada, John Yeakel, et al.
Blood
|
February 9, 2008
Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival
Farshid Dayyani, Jianfeng Wang, Jing-Ruey J Yeh, et al.
Cancer
|
February 18, 2010
Cause of death in patients with lower-risk myelodysplastic syndrome
Farshid Dayyani, Anthony P Conley, Sara S Strom, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)
Thomas Muley, Vinzent Rolny, Ying He, et al.
BMC Cancer
|
September 8, 2016
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
Farshid Dayyani, Amado J Zurita, Graciela M Nogueras-González, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 9, 2021
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure-safety analyses in patients with metastatic pancreatic cancer
Karl Brendel, Tanios Bekaii-Saab, Patrick M Boland, et al.
The Oncologist
|
June 21, 2024
Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers
Bushra Shariff, Reagan M Barnett, Farshid Dayyani, et al.
The International Journal of Biological Markers
|
March 29, 2024
A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis
Bruno Köhler, Marta Bes, Henry Lik-Yuen Chan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 6, 2021
First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study
Zev A Wainberg, Tanios Bekaii-Saab, Patrick M Boland, et al.
Cancers
|
January 21, 2022
Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach
May T Cho, Sepideh Gholami, Dorina Gui, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 115) with videos related to
Sort By:
Page
of 12
Journal of Gastrointestinal Oncology
|
March 12, 2026
The association between adherence to elective nodal volume guidelines and reduced distant metastasis in esophageal and gastroesophageal junction cancer: a retrospective analysis of elective nodal irradiation
Jared Lyons, Garrett Harada, John Yeakel, et al.
Blood
|
February 9, 2008
Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival
Farshid Dayyani, Jianfeng Wang, Jing-Ruey J Yeh, et al.
Cancer
|
February 18, 2010
Cause of death in patients with lower-risk myelodysplastic syndrome
Farshid Dayyani, Anthony P Conley, Sara S Strom, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)
Thomas Muley, Vinzent Rolny, Ying He, et al.
BMC Cancer
|
September 8, 2016
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
Farshid Dayyani, Amado J Zurita, Graciela M Nogueras-González, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 9, 2021
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure-safety analyses in patients with metastatic pancreatic cancer
Karl Brendel, Tanios Bekaii-Saab, Patrick M Boland, et al.
The Oncologist
|
June 21, 2024
Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers
Bushra Shariff, Reagan M Barnett, Farshid Dayyani, et al.
The International Journal of Biological Markers
|
March 29, 2024
A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis
Bruno Köhler, Marta Bes, Henry Lik-Yuen Chan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 6, 2021
First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study
Zev A Wainberg, Tanios Bekaii-Saab, Patrick M Boland, et al.
Cancers
|
January 21, 2022
Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach
May T Cho, Sepideh Gholami, Dorina Gui, et al.
Page
of 12